staurosporine aglycone has been researched along with Hodgkin Disease in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renné, C | 1 |
| Minner, S | 1 |
| Küppers, R | 1 |
| Hansmann, ML | 1 |
| Bräuninger, A | 1 |
1 other study available for staurosporine aglycone and Hodgkin Disease
| Article | Year |
|---|---|
Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines.
Topics: B-Lymphocytes; Carbazoles; Cell Line, Tumor; Hodgkin Disease; Humans; In Situ Hybridization, Fluores | 2008 |